Strategizing biodegradable polymeric nanoparticles to cross the biological barriers for cancer targeting.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
30 Jun 2019
Historique:
received: 10 02 2019
revised: 13 05 2019
accepted: 14 05 2019
pubmed: 19 5 2019
medline: 18 12 2019
entrez: 19 5 2019
Statut: ppublish

Résumé

The biological barriers in the body have been fabricated by nature to protect the body from foreign molecules. The successful delivery of drugs is limited and being challenged by these biological barriers including the gastrointestinal tract, brain, skin, lungs, nose, mouth mucosa, and immune system. In this review article, we envisage to understand the functionalities of these barriers and revealing various drug-loaded biodegradable polymeric nanoparticles to overcome these barriers and deliver the entrapped drugs to cancer targeted site. Apart from it, tissue-specific multifunctional ligands, linkers and transporters when employed imparts an effective active delivery strategy by receptor-mediated transcytosis. Together, these strategies enable to deliver various drugs across the biological membranes for the treatment of solid tumors and malignant cancer.

Identifiants

pubmed: 31102804
pii: S0378-5173(19)30401-6
doi: 10.1016/j.ijpharm.2019.05.042
pii:
doi:

Substances chimiques

Polymers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

509-522

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Hira Choudhury (H)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Bapi Gorain (B)

School of Pharmacy, Faculty of Health and Medical Science, Taylor's University, Subang Jaya, 47500 Selangor, Malaysia. Electronic address: bapi.gorain@taylors.edu.my.

Manisha Pandey (M)

School of Pharmacy, International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia.

Rajneet Kaur Khurana (RK)

University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Studies, Panjab University, Chandigarh 160014, India.

Prashant Kesharwani (P)

School of Pharmaceutical Education and Research, Jamia Hamdard (Hamdard University), New Delhi 110062, India. Electronic address: prashantdops@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH